Astrocyte Pharmaceuticals Inc.

About Astrocyte Pharmaceuticals Inc.

Astrocyte Pharmaceuticals is a company focused on developing innovative neuroprotection therapies for treating brain injuries and diseases, including Traumatic Brain Injuries (TBI), concussions, stroke, and neurodegenerative disorders.

Products & Services

Neuroprotection Therapies:Therapies aimed at treating acute ischemic stroke, TBI, concussion, and other brain injuries.

AST-004:An investigational new drug for cerebroprotection, under development for various brain injury treatments.

Specialties

Neuroprotection Therapies Brain Injury Treatment Astrocyte Research Stroke Treatment TBI and Concussion Healing Neurodegenerative Disorders

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Pre-Series B Bridge T: - FT: Pre-Series B Bridge	A: 6000000 MR: - FA: $6M FAN: 6000000	D: 2023-08-18 FD: 2023-08-18	9 investors

Pre-Series B Bridge Latest

2023-08-18

$6.0M

9 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

W

William S. Korinek, Ph.D.

Co-Founder and Chief Executive Officer

J

James D. Lechleiter

Co-Founder and Advisor, Professor of Cellular and Structural Biology

T

Theodore E. Liston

Vice-President of Research

K

Kevin Sheth

Chief Medical Advisor

L

Lisa Manna

Vice-President of Clinical Development Operations

R

Russell B. Poe

Head of Chemistry and Manufacturing Controls (CMC)

View 13 more team members with Pro

Unlock Full Team Directory

Recent News